CLDF Title
Contact Us | Bookmark
HBV HE HCC HCV NASH-NAFLD
About CLDF Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
UEGW 2015     Banner2   IC-Hep
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
Kannalife eyes share float to fund cannabis-based medicine
02-25-2016
What stair-climbing speed may say about surgery outcomes
02-25-2016
Fatty liver adds to cardiovascular risk in obese type 2 diabetics
02-22-2016
Drinking more coffee may undo liver damage from booze
02-18-2016
View Complete News Library
 
 
May 4-7
22ND ANNUAL INTERNATIONAL CONGRESS OF THE INTERNATIONAL LIVER TRANSPLANTATION SOCIETY (ILTS)
Seoul, South Korea
May 25-28
49th ANNUAL MEETING- THE EUROPEAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION (ESPGHAN)
Athens, Greece
May 21-24
DDW 2016
San Diego, CA
June 11-15
AMERICAN TRANSPLANT CONGRESS
Boston, Massachusetts
View all Congresses
 
 
 
  Line  
  Featured Abstracts          
 
Patient-reported Outcomes in Asian Patients With Chronic Hepatitis C Treated With Ledipasvir and Sofosbuvir
 
Hepatitis C virus testing and treatment among persons receiving buprenorphine in an office-based program for opioid use disorders
 
Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge
 
Perspectives on treating hepatitis C infection in the liver transplantation setting
 
Elbasvir/Grazoprevir: First Global Approval
 
Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies
 
 
Gastroenterologists Have Suboptimal Hepatitis B Virus Screening Rates in Patients Receiving Immunosuppressive Therapy
 
Are current screening protocols for chronic hepatitis B virus infection adequate?
 
Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus
 
Hepatitis B virus and hepatitis C virus infection in healthcare workers
 
Techniques for Transjugular Intrahepatic Portosystemic Shunt Reduction and Occlusion
 
Impact of depressive symptoms and hepatic encephalopathy on health-related quality of life in cirrhotic hepatitis C patients
 
 
Cognitive Impairment Predicts The Occurrence Of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt
 
RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial
 
Disentangling the effects of race and socioeconomic factors on liver transplantation rates for hepatocellular carcinoma
 
Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer
 
Prognostic significance of adverse events in patients with hepatocellular carcinoma treated with sorafenib
 
Hepatocellular carcinoma: Where are we?
 
 
          View All Abstracts  
  Line  
                     
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Telewebs
Webcasts
Slide Library
Abstract Library
 
 
NASH/NAFLD
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
         
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2016 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.